Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
The in-depth article examines how the onset of flu season has the potential to further complicate testing challenges posed by COVID-19.
After a traumatic fall, Andrew “Roo” Yori’s persistence and athletic gifts allowed him to achieve his dream of becoming an American Ninja Warrior in 2016. Roo uses his celebrity to raise funds for his dog rescue foundation, which helps support other programs and organizations that are making an impact for homeless dogs in their community.
This week’s research roundup features a study on inherited causes of clonal haematopoiesis in 97,691 whole genomes.
Top highlights include: facts about the flu vaccine, Halloween masks vs cloth masks, and safe Halloween activities during the pandemic.
This “Phlebotomy Webinar” will focus on the role of the phlebotomist and the changes adapted to provide service safely to COVID positive patients in different service areas (ED, ICU vs General floors).
Flu season is just now unfolding. But this time, it’s piggy-backed with a pandemic, which threatens to spike with the colder weather as people huddle indoors. Adding to this conundrum is the unsettling fact that, for both COVID-19 and the flu, the symptoms overlap.
A conversation with Matt Wood, director of Supply Chain Solutions developed by Mayo Clinic, about a little-known program available to help hospitals and other organizations greatly reduce their freight expenses.
William Sukov, M.D., provides an overview of the MDM2 gene amplification assay — a test that looks for amplification of the MDM2 gene region on chromosome 12q. He reviews when this test should be ordered, how it compares to other test options, and how its results can affect patient care.
This week’s research roundup features a study on the novel methylated DNA markers in the surveillance of colorectal cancer recurrence.
Top highlights include: increased alcohol use during the pandemic, contract tracing slows the spread, FDA sets stricter standards for COVID-19 vaccine development, and Halloween safety tips during the pandemic.
This week’s research roundup features a study on the implications of MYC rearrangements in newly diagnosed multiple myeloma patients.
The concept of at-home testing for COVID-19 sounds straightforward. But there's nuance to it that's important to understand. Right now, an at-home test for COVID-19 is not available, although there may be one coming soon. But in some areas, at-home sample collection is an option at this time.